Potential applications of siRNA for pain therapy

Bibliography

• BIRCH S: The CNS Outlook to 2007, Reuters Business Insight Healthcare. Datamonitor PLC. (2003):1–200.
   Google Scholar
• ZIMMERMAN M: Pathobiology of neuropathic pain. Eur. I Pharin. (2001) 429:23–37.
   PubMed Web of Science ®Google Scholar
• ROWBOTHAM M, HARDEN N, STACEY B et al.: Gabapentin for the treatment of postherpetic neuralgia: a randomised controlled trial. JAMA (1998) 280(21):1837–1842.
   PubMed Web of Science ®Google Scholar
• RICE, A, MATON S: Postherpetic neuralgia study group: Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain (2001) 94:215–224.
   PubMed Web of Science ®Google Scholar
• NITU A, WALLIHAN R, SKLJAREVSKI V, RAMADAN N: Emerging trends in the pharmacotherapy of chronic pain. Expert Opin. Investig. Drugs (2003) 12(4):545–559.
   PubMed Web of Science ®Google Scholar
• MCMANUS M, SHARP P: Gene silencing in mammals by small interfering RNAs. Nat. Rev Genet. (2002) 3:737–747.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review of siRNA.
   Google Scholar
• FIRE A, XU S, MONTGOMERY M, KOSTAS S, DRIVERS, MELLO C: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 391(6669):806–811.
   PubMed Web of Science ®Google Scholar
• BERNSTEIN E, CAUDY A, HAMMOND S, HANNON GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference in cultured mammalian cells. Nature (2001) 409(6818):363–366.
   PubMed Web of Science ®Google Scholar
• ELBASHIR S, HARBORTH J, LENDECKEL W et al.: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 411(6836):494–498.
   PubMed Web of Science ®Google Scholar
• STARK G, KERR I, WILLIAMS B et al.: How cells respond to interferons. Anna. Rev Biochein. (1998) 67:227–264.
   PubMed Web of Science ®Google Scholar
• SCHERER L, ROSSI J: Approaches for the sequence-specific knockdown of mRNA. (2003) Nat. Biotechnol 21(12):1457–1465.
   Google Scholar
• •An informative review comparing AS0s, ribozymes, DNAzymes and RNAi approaches for mRNA knockdowns.
   Google Scholar
• MAKIMURA H, MIZUNO TM, MASTAITLIS JVV, AGAMI R MOBBS CV: Reducing hypothalmic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neuroscience (2003) 3:18.
   Google Scholar
• SONG E, LEES, WANG J et al.: RNA interference targeting Fas protects mice from fulminant hepatitis, Nat. Med. (2003) 9(3):347–351.
   Web of Science ®Google Scholar
• VERMA U, SURABHI R, SCHMALTIEG A et al.: Small interfering RNAs directed against I3-catanin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. (2003) 9(4):1291–1300.
   PubMed Web of Science ®Google Scholar
• SORENSEN D, LEIRDAL M, SIOUD M: Gene silencing by systemic delivery of synthetic siRNAs in adult mice. j Ma Biol. (2003) 327(4):761–766.
   Web of Science ®Google Scholar
• •Recognises that different siRNAs demonstrate various levels of potency and require characterisation before initiation of in vivo studies, that reagent delivery to target tissue may require specialist reagents, although the use of liposomes may not be permitted in man, and the use of siRNAs to inhibit a protein with a known role in several disease indications.
   Google Scholar
• FILLEUR S, COURTIN A, AIT-SI-ALI S et al: siRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularisation and growth. Cancer Res. (2003) 63:3919–3922.
   PubMed Web of Science ®Google Scholar
• REICH S, FOSNOT J, KUROKI A et al.: small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularisation in a mouse model. Vis. (2003) 9:210–216.
   Google Scholar
• ZENDER L, HUTKER S, LIEDTKE C et al.: Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Nati Acad. Sci USA (2003) 100(13):7797–7802.
   PubMed Web of Science ®Google Scholar
• DORN G, PATEL S, WOTHERSPOON G et al.: RNA interference blocks chronic pain in vivo. Br. Neurosci. Assoc. Abstr. (2003) 17:P63.09.
   Google Scholar
• ••The first demonstration of the utility ofsiRNA in chronic pain.
   Google Scholar
• DORN G, PATEL S, WOTHERSPOON G et al.: RNA interference blocks chronic pain in vivo. (2004) (In press).
   Google Scholar
• BARCLAY, J, PATEL S, DORN G et al: Functional downregulation of P2X3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory pain. Neurosci. (2002) 22:8139–8147.
   PubMed Web of Science ®Google Scholar
• HONORE P, KAGE K, MIKUSA J et al.: Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats. Pain (2002) 99:11–19.
   PubMed Web of Science ®Google Scholar
• COCKAYNE D, HAMILTON S, ZHU Q et al.: Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature (2000) 407:1011–1015.
   PubMed Web of Science ®Google Scholar
• SOUSLOVA V, CESARE P, DINGY et al.: Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature (2000) 407:1015–1017.
   PubMed Web of Science ®Google Scholar
• JARVIS M, BURGARD E, MCGARAUGHTY S et al: A-317491, a novel potent and selective nonnucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. USA (2002) 99(26):17179–17184.
   PubMed Web of Science ®Google Scholar
• MCGARAUGHTY S, WISMER C, ZHU C et al: Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br. Phannaca (2003) 140:1381–1388.
   Web of Science ®Google Scholar
• LAVERY K, KING T:Antisense and RNAi: powerful tools in drug discovery and validation. Curr: Opin. Drug Discov. (2003) 6(4):561–569.
   PubMed Web of Science ®Google Scholar
• MANTYH P, CLOHISY D, KOLTZENBURG M et al.: Molecular mechanisms of cancer pain. Nat. Rev (2002) 20:201–209.
   Google Scholar
• CRAIG A: Pain mechanisms: labelled lines versus convergence in central processing. Ann. Rev Neurosci. (2003) 26:1–30.
   PubMed Web of Science ®Google Scholar
• SELTZER Z, DUBNER R, SHIR Y: A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain (1990) 43:205–218.
   PubMed Web of Science ®Google Scholar
• LAI J, PORRECA F, HUNTER J et al: Voltage-gated sodium channels and hyperalgesia. Ann. Rev Phannaca Toxicol. (2004) 44:371–397.
   PubMed Web of Science ®Google Scholar
• LAI J, GOLD M, KIM C et al.: Inhibition of neuropathic pain by decreased expression of the tetrodotoxin resistant sodium channel, Nav1.8. Pain (2002) 95:143–152.
   Google Scholar
• ••Demonstrates that antisense-mediatedknockdown of this channel reverses signs of abnormal pain in a model of chronic pain, suggesting it could be a key target for intervention in pain.
   Google Scholar
• GOLD M, VVEINREICH D, KIM C et al: Redistribution of Nav1.8 in uninjured axons enables neuropathic pain. Neurosci. (2003) 23:153–186.
   Google Scholar
• PORECCA F, LAI J, BIAN D et al.: A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/and NaN/5N52, in rat models of chronic pain. Proc. Nati Acad. Sci. USA (1999) 99:7640–7644.
   Google Scholar
• AUGUSTINE G, CHARLTON M, SMITH S: Calcium action in synaptic transmitter release. Ann. Rev Neurosci. (1987) 10:633–693.
   PubMed Web of Science ®Google Scholar
• HEADING C: Ziconotide. Curr: Opin. CPNS Investig. Drugs (1999) 1:153–166.
   Google Scholar
• AL-GHOUL W, LI VOLSI G, WEINBERG R et al: Glutamate immunocytochemistry in the dorsal horn after injury or stimulation of the sciatic nerves of rats. Brain Res. Bull. (1993) 340:453–459.
   Google Scholar
• FUNDYTUS M, YASHPAL K, CHABOT J-C et al: Knockdown of spinal metabotropic glutamate receptor 1 (mGluR1) alleviates pain and restores opioid efficacy after nerve injury in rats. Br: J. Phann. (2001) 132:354–367.
   Google Scholar
• HAINS B, KLEIN J, SAAB C et al.: Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. Neurosci. (2003) 23(26):8881–8892.
   Google Scholar
• NELSON P, SOMA L, LAVI E: Microglia in diseases of the central nervous system. Ann. Med. (2002) 34(7-8):491–500.
   PubMed Web of Science ®Google Scholar
• TSUDA M, SHIGEMOTO-MOGAMI Y, KOIZUMI S: P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature (2003) 424:778–783.
   PubMed Web of Science ®Google Scholar
• ••This study demonstrates that microglialgenes are amenable to antisense knockdown and could be potential targets for chronic pain intervention.
   Google Scholar
• KEST B, HOPKINS E, PALMESE C et al.: Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains. (2002) Phannaca Biochein. Behav. 73(0821–828.
   Google Scholar
• PRZEWLOCKA B, SIEJA A, STAROWICZ K et al.: Knockdown of spinal opioid receptors by antisense targeting I3-arrestin reduces morphine tolerance and allodynia in rat. Neurosci. Lett. (2002) 325:107–110.
   PubMed Web of Science ®Google Scholar
• FERGUSON S, DOWNEY W III, COLAPIETRO A et al.: Role of I3-arrestin in mediation agonist-promoted G protein-coupled receptor internalisation. Science (1996) 271:363–366.
   PubMed Web of Science ®Google Scholar
• WU C, GARRY M, ZOLLO R et al.: Gene therapy for the management of pain. Anesthesia (2001) 94:1119–1131.
   Google Scholar
• MCCAFFERY A, MEUSE L, PHAM T et al.: RNA interference in adult mice. Nature (2002) 418(6893):38–39.
   PubMed Web of Science ®Google Scholar
• LEWIS D, HAGSTROM J, LOOMIS A et al.: Efficient delivery of siRNA for inhibition of gene expression in postnatal mice (2002) Nat. Genet. 32(1):107–108.
   PubMedGoogle Scholar
• •Shows that synthetic, duplexed oligoribonudeotides bearing no modifications are sufficiently stable in mice for some applications through intravenous injection and that a small but relevant set of body organs can be reached without the need for complex formulations.
   Google Scholar
• BARDON A, SIERAKOWSKA H, SHUGAR D: Human pancreatic-type ribonucleases with activity against double-stranded ribonucleic acids. Biochlin. Biophys. Acta (1976) 438(2):461–473.
   PubMed Web of Science ®Google Scholar
• ELBASHIR S, HARBORTH J, WEBER K et al.: Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods (2002) 26:199–213.
   PubMed Web of Science ®Google Scholar
• REYNOLDS A, LEAKE D, BOESE Q et al.: Rational siRNA design for RNA interference. Nat. Biotechna (2004) (In Press) [Epub ahead of print].
   Google Scholar
• •Describes features associated with siRNA functionality: low G/C content, a bias towards low internal stability at the sense strand 3'-terminus, lack of inverted repeats, and sense strand base preferences.
   Google Scholar
• FREIER S, KIERZEK R, JAEGER J et al.: Improved free-energy parameters for predictions of RNA duplex stability. Proc. Natl. Acad. Sci. USA (1986) 83(24):9373–9377.
   PubMed Web of Science ®Google Scholar
• CHI J, CHANG H, WANG N et Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA (2003) 100(11):6343–6346.
   PubMed Web of Science ®Google Scholar
• •This study explores the selectivity of RNAi.
   Google Scholar
• SEMIZAROV D, FROST L, SARTHY A et al.: Specificity of short interfering RNA determined through gene expression signatures. (2003) Proc. Natl. Acad. Sci. USA 100(11):6347–6352.
   Google Scholar
• •This study explores the selectivity of RNAi.
   Google Scholar
• JACKSON A, BARTZ S, SCHELTER J et al.: Expression profiling reveals off-target regulation by RNAi. Nat. Biotechnol. (2003) 21(6):635–638.
   PubMed Web of Science ®Google Scholar
• •This study explores the off-target effects of RNAi.
   Google Scholar
• KISIELOW M, KLEINER S, NAGASAWA M, FAISAL A, NAGAMINE M: Isoform-specific knockdown and expression of adaptor protein shc A using small interfering RNA. Bloc/min. J. (2002) 363(1):1–5.
   PubMedGoogle Scholar
• SLEDZ C, HOLKO M, DE VEER M et al.: Activation of the interferon system by short-interfering RNAs. (2003) Nat. Cell Biol. 5(9):834–839.
   Google Scholar
• BRIDGE A, PEBERNARD S, DUCRAUX A et al.: Induction of an interferon response by RNAi vectors in mammalian cells. (2003) Nat. Genet. 34(3):263–264.
   PubMedGoogle Scholar